Argenx Se ADR (NQ: ARGX )
525.00
+0.10
(+0.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Argenx Se ADR
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28250.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5443.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/11/aapharma_7.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/29/aapharma_14.png?width=1200&height=800&fit=crop)
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
September 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/21/aapharma_10.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/11/bz-pharma_6.jpg?width=1200&height=800&fit=crop)
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 11, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/11/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/07/29/aapharma_12.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_23320.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/28/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7221.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7091.jpeg?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_22360.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_5744.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_12159.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/05/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_5451.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_4087.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_9917.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/red-blood-cell-gc6575ac93_1920_2.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220331006063/en/1333817/5/BusinessWire_argenx_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/lab-5740505_1920_12.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/thumbs_up.png)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3934.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.